UPDATE 2-Big loss shows Alcon's turnaround a work in progress [Reuters]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Reuters
UPDATE 2-Big loss shows Alcon's turnaround a work in progress - Reuters 3 Min Read * Q2 net loss $390 mln vs profit of $15 mln a year earlier * Results affected by tax and amortisation hits * Shares fall as much as 2.9% (Recasts first paragraph, adds comment from analyst) By John Miller ZURICH, Aug 21 (Reuters) - Alcon posted a big second-quarter loss, showing the Swiss-listed eye care company’s pursuit of a turnaround remains a work in progress following its spin-off from Novartis earlier this year. Alcon reported on Tuesday a net loss of $390 million, or 80 cents per share, for the three months ended June 30, compared with net income of $15 million, or 3 cents per share, in the previous year. Net sales rose 5% in constant currencies to $1.86 billion, in line with the $1.87 billion estimate in a Refinitiv poll. The Geneva-headquartered company booked a $294 million second-quarter tax hit, up from just $9 million in the year-earlier period, after it was forced to re-evaluate deferred
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Neurocrine: Success Continues To Roll In With Positive MDD Treatment Data [Seeking Alpha]Seeking Alpha
- AACN's New Web Resource Focuses on Preparing Nurses with Essential Well-Being and Leadership Competencies [Yahoo! Finance]Yahoo! Finance
- Justice Department is investigating McKinsey consulting firm's role in opioid epidemic [CNN]CNN
- BioNJ Announces Lineup for BioPartnering Conference [Yahoo! Finance]Yahoo! Finance
- CURE Media Group and Oncology Nursing News® announce Meaghan Mooney, B.S.N., RN, OCN, as the winner of the 2024 Extraordinary Healer® Award [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website